TELAVINCE 300
Item requires a valid prescription
Manufactured By Steris Healthcare Pvt Ltd
Composition Tenofovir Disoproxil Fumarate Tablets ip 300 mg
Rs 1036.00
MRP Rs 1480.00
(30% OFF)
Includes all taxes
Package SIZE
( 30 Tablets )
100% Authentic
Products
Free
Shipping*
Products
Return Policy
Description:
TELAVINCE 300 is a high-quality antiviral medication containing Tenofovir Disoproxil Fumarate 300 mg, specifically formulated for the effective management of HIV-1 infection and chronic Hepatitis B in adults and adolescents. Manufactured under strict pharmaceutical standards, TELAVINCE 300 offers consistent, potent, and clinically proven antiviral action, helping to suppress viral replication and improve immune function.
Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). It works by interfering with the enzyme reverse transcriptase, which is essential for viral replication in HIV and Hepatitis B viruses. By inhibiting this enzyme, TELAVINCE 300 reduces the amount of virus in the body, helping to prevent further immune system damage and liver complications.
Key Indications:
TELAVINCE 300 is indicated for:
-
HIV-1 Infection: In combination with other antiretroviral agents for the treatment of HIV-1 in adults and adolescents (aged 12 years and older, weighing at least 35 kg).
-
Chronic Hepatitis B: For the treatment of chronic hepatitis B virus infection in adults and adolescents with compensated liver disease and evidence of active viral replication.
Mechanism of Action:
Tenofovir Disoproxil Fumarate is a prodrug of tenofovir, which, once absorbed and metabolized in the body, is converted into tenofovir diphosphate, the active form. Tenofovir diphosphate acts as a competitive inhibitor of reverse transcriptase, incorporating itself into the viral DNA chain and causing premature chain termination. This process disrupts the life cycle of the virus, significantly reducing its ability to multiply and spread.
Dosage and Administration:
-
Recommended Dose for Adults and Adolescents (≥12 years, ≥35 kg): One tablet (300 mg) once daily, preferably with food.
-
For HIV Treatment: Administer in combination with other antiretroviral medications as per the treatment regimen.
-
For Chronic Hepatitis B: Monotherapy or as part of combination therapy, depending on patient condition and physician's assessment.
Dosage adjustments may be required in patients with renal impairment. Close monitoring is recommended for patients with existing kidney disease.
Key Benefits of TELAVINCE 300:
-
Potent Antiviral Action: Rapid and sustained suppression of HIV and HBV replication.
-
Once-Daily Dosing: Improves patient compliance and treatment adherence.
-
Backed by Clinical Research: Proven efficacy in managing viral load and improving immune markers (CD4 count).
-
Trusted Quality: Manufactured under GMP-certified facilities with stringent quality control processes.
-
Part of First-Line Therapy: Recommended in various national and international treatment guidelines for HIV and Hepatitis B.
Safety and Precautions:
-
Renal Monitoring: Tenofovir may affect kidney function. Routine renal function tests are recommended before and during treatment.
-
Bone Mineral Density: Long-term use may reduce bone mineral density. Consider monitoring in patients at risk of osteopenia or osteoporosis.
-
Hepatic Flare: Discontinuation of therapy in hepatitis B patients may result in severe acute exacerbations. Liver function should be closely monitored post-treatment.
-
Lactic Acidosis and Hepatomegaly: Rare but serious side effects. Patients presenting symptoms such as abdominal pain, fatigue, or difficulty breathing should seek immediate medical attention.
Possible Side Effects:
Most patients tolerate TELAVINCE 300 well. However, some may experience:
-
Nausea
-
Diarrhea
-
Headache
-
Fatigue
-
Rash
-
Dizziness
-
Decreased bone mineral density
-
Renal impairment (in rare cases)
If any side effects persist or worsen, consult a healthcare professional immediately.
Storage Instructions:
-
Store in a cool, dry place below 30°C.
-
Protect from light and moisture.
-
Keep out of reach of children.
Why Choose TELAVINCE 300?
TELAVINCE 300 offers a dependable, clinically validated solution for the long-term management of HIV and Hepatitis B. With its once-daily dosing and proven effectiveness, TELAVINCE 300 is an ideal choice for patients and healthcare providers looking for quality, safety, and therapeutic reliability. It is manufactured by a trusted name in healthcare, ensuring every tablet meets global pharmaceutical standards.
Disclaimer:
This product description is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or healthcare provider before starting any medication.